Paul Billings has been named chief medical officer and senior vice president of medical affairs of Natera (NASDAQ: [[ticker:NTRA]]). Billings’ experience includes serving as chief medical officer of Life Technologies and as consulting chief medical officer of Thermo Fisher Scientific’s (NYSE: [[ticker:TMO]]) genetic sciences division. San Carlos, CA-based Natera markets genetic assays, including prenatal tests and tests to identify the cause of miscarriages.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
